Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

330 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-04-30

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The advent of highly active antiretroviral treatment has resulted in the survival into adolescence of an increasing proportion of infants and children with perinatal HIV infection in Senegal. However, the transformation of HIV into a chronic disease needing lifelong antiretroviral treatment (ART) raises new challenges, among others related to a disturbance of glucose metabolism, lipid abnormalities, in addition to the potential effects on children's growth and puberty. Little is known on nutritional and metabolic changes in HIV-infected children on ART in Africa, while implementation of the latest WHO recommendations should eventually lead to an increase in the number of children on ART in this region. Moreover, bio-clinical evolution of untreated children is poorly documented in the African context. It therefore urgently needed to institute a cohort study to evaluate, in the long term, the impact of HIV infection and/or ART on nutritional and metabolic disorders and to characterize the risk factors of their occurrence in children and adolescents infected as they move through adolescent into adulthood.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cohort of HIV-infected Children

NCT03235258

Children Infected by HIV

COMPLETED

Trial of Vitamins Among Children of HIV-infected Women

NCT00197730

HIV Infections Pregnancy Complications

COMPLETED PHASE3

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

NCT00000873

HIV Infections

COMPLETED NA

Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo

NCT03048669

HIV/AIDS Antiretroviral Therapy Pregnancy Outcomes +1 more

COMPLETED NA

Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring

NCT01555723

HIV Infection

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV-1

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV-1 infection
* Age equal or above 2 years and bellow 16 years
* Follow-up in the participating site
* Informed consent signed by at least on of the parents or legal guardian who is aware of the child's HIV status

Exclusion Criteria

* HIV-2 or HIV-1+2 infection
* children represented by a legal guardian who is not informed about the child's HIV status
* Unable to comply with study requirements or procedures according to the investigator's opinion

Minimum Eligible Age

2 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No